Ministry of Health and Family Welfare press release · 25 May 2026 · pibtracker filter

Indian Council of Medical Research organizes India’s largest biomedical innovation and technology transfer event “Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect” in New Delhi

PRID2264989 MinistryMinistry of Health and Family Welfare Released25 May 2026 Reading12 min

Union MoS Shri Prataprao Jadhav says India is emerging as a global source of affordable healthcare technologies through stronger science-industry partnerships ICMR launches first-of-its-kind Innovator–Industry Platform, transfers 41 Public Health Technologies to Industry India witnesses first-ever transfer of inactivated KFD and Chandipura virus biomaterials to industry partners to strengthen biomedical research and vaccine manufacturing “India has scientific capability to emerge as global leader in health technologies”: Member, NITI Aayog Dr Gobardhan Das Secy DHR & DG, ICMR Dr. Rajiv Bahl says Medical Innovations Patent Mitra accelerates the journey of indigenous biomedical research from laboratories to people Posted On: 25 MAY 2026 4:57PM by PIB Delhi The Indian Council of Medical Research (ICMR), under the Department of Health Research, Ministry of Health and Family Welfare, Government of India, successfully organized “Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect”—India’s largest biomedical and technology transfer facilitation event today, at the Manekshaw Centre, New Delhi. The event marked the establishment of one of the country’s first structured platforms dedicated to biomedical innovation showcasing and technology transfer under the ICMR Medical Innovation Patent Mitra initiative. The initiative aims to translate indigenous biomedical research into accessible, real-world healthcare solutions through strong industry partnerships. The event was inaugurated by Shri Prataprao Ganpatrao Jadhav, Union Minister of State (Independent Charge), Ministry of Ayush, and Minister of State, Ministry of Health and Family Welfare in presence of Prof. Gobardhan Das, Member NITI. Delivering the keynote address, the Minister of State Shri Jadhav said, “This initiative marks a decisive step in connecting Indian science with industry, ensuring that innovations developed in our laboratories translate into technologies that strengthen public health and advance Viksit Bharat. India is moving from being a consumer of health technologies to becoming a global source of affordable and innovative healthcare solutions, powered by institutions like ICMR and strong industry partnerships.” Speaking on the occasion, Dr Gobardhan Das, Member, NITI Aayog said, “India has the scientific capability and innovation ecosystem to emerge as a global leader in health technologies. Medical Innovation Patent Mitra will play a crucial role in protecting intellectual property, enabling technology transfer and accelerating the journey of indigenous innovations from laboratories to society.” Dr. Rajiv Bahl, Director General, ICMR and Secretary, Department of Health Research, said, “Medical Innovations Patent Mitra reflects ICMR’s commitment to ensuring that cutting-edge research moves beyond laboratories to reach people through strong industry partnerships and impactful technology transfer.” During the event, the ‘Indian Biomedical Patent Landscape Report’ and the ‘Technology Compendium’ were also released, marking a significant step towards strengthening India’s biomedical innovation, intellectual property and technology transfer ecosystem. A major highlight of the event was the transfer of 41 public health technologies from ICMR institutes and innovators to industry partners for further development, manufacturing and commercialization. These technologies include advanced diagnostics, vaccines, medical devices and biomedical solutions addressing critical public health priorities. Among the technologies transferred were glycoconjugate and recombinant vaccines for Typhoid and Paratyphoid, as well as diagnostic technologies for diseases such as Japanese Encephalitis, Tuberculosis and Mpox. In another significant first, well-characterized biomaterials including inactivated KFD and Chandipura viruses were also transferred to industry partners, strengthening India’s biomedical research and manufacturing ecosystem. The event also showcased more than 100 technologies in diagnostics, therapeutics and medical devices developed by ICMR institutes, researchers and startups, while facilitating direct engagement between innovators and industry stakeholders. Innovators and Industry connect initiative is expected to play a pivotal role in strengthening India’s Biomedical sector for Viksit Bharat 2047 with stronger Public-Private partnership. *** SR/GS (Release ID: 2264989) Visitor Counter : 1242 Read this release in: Telugu , Urdu , हिन्दी , Punjabi , Tamil Ministry of Health and Family Welfare Indian Council of Medical Research organizes India’s largest biomedical innovation and technology transfer event “Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect” in New Delhi Union MoS Shri Prataprao Jadhav says India is emerging as a global source of affordable healthcare technologies through stronger science-industry partnerships ICMR launches first-of-its-kind Innovator–Industry Platform, transfers 41 Public Health Technologies to Industry India witnesses first-ever transfer of inactivated KFD and Chandipura virus biomaterials to industry partners to strengthen biomedical research and vaccine manufacturing “India has scientific capability to emerge as global leader in health technologies”: Member, NITI Aayog Dr Gobardhan Das Secy DHR & DG, ICMR Dr. Rajiv Bahl says Medical Innovations Patent Mitra accelerates the journey of indigenous biomedical research from laboratories to people Posted On: 25 MAY 2026 4:57PM by PIB Delhi The Indian Council of Medical Research (ICMR), under the Department of Health Research, Ministry of Health and Family Welfare, Government of India, successfully organized “Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect”—India’s largest biomedical and technology transfer facilitation event today, at the Manekshaw Centre, New Delhi. The event marked the establishment of one of the country’s first structured platforms dedicated to biomedical innovation showcasing and technology transfer under the ICMR Medical Innovation Patent Mitra initiative. The initiative aims to translate indigenous biomedical research into accessible, real-world healthcare solutions through strong industry partnerships. The event was inaugurated by Shri Prataprao Ganpatrao Jadhav, Union Minister of State (Independent Charge), Ministry of Ayush, and Minister of State, Ministry of Health and Family Welfare in presence of Prof. Gobardhan Das, Member NITI. Delivering the keynote address, the Minister of State Shri Jadhav said, “This initiative marks a decisive step in connecting Indian science with industry, ensuring that innovations developed in our laboratories translate into technologies that strengthen public health and advance Viksit Bharat. India is moving from being a consumer of health technologies to becoming a global source of affordable and innovative healthcare solutions, powered by institutions like ICMR and strong industry partnerships.” Speaking on the occasion, Dr Gobardhan Das, Member, NITI Aayog said, “India has the scientific capability and innovation ecosystem to emerge as a global leader in health technologies. Medical Innovation Patent Mitra will play a crucial role in protecting intellectual property, enabling technology transfer and accelerating the journey of indigenous innovations from laboratories to society.” Dr. Rajiv Bahl, Director General, ICMR and Secretary, Department of Health Research, said, “Medical Innovations Patent Mitra reflects ICMR’s commitment to ensuring that cutting-edge research moves beyond laboratories to reach people through strong industry partnerships and impactful technology transfer.” During the event, the ‘Indian Biomedical Patent Landscape Report’ and the ‘Technology Compendium’ were also released, marking a significant step towards strengthening India’s biomedical innovation, intellectual property and technology transfer ecosystem. A major highlight of the event was the transfer of 41 public health technologies from ICMR institutes and innovators to industry partners for further development, manufacturing and commercialization. These technologies include advanced diagnostics, vaccines, medical devices and biomedical solutions addressing critical public health priorities. Among the technologies transferred were glycoconjugate and recombinant vaccines for Typhoid and Paratyphoid, as well as diagnostic technologies for diseases such as Japanese Encephalitis, Tuberculosis and Mpox. In another significant first, well-characterized biomaterials including inactivated KFD and Chandipura viruses were also transferred to industry partners, strengthening India’s biomedical research and manufacturing ecosystem. The event also showcased more than 100 technologies in diagnostics, therapeutics and medical devices developed by ICMR institutes, researchers and startups, while facilitating direct engagement between innovators and industry stakeholders. Innovators and Industry connect initiative is expected to play a pivotal role in strengthening India’s Biomedical sector for Viksit Bharat 2047 with stronger Public-Private partnership. *** SR/GS (Release ID: 2264989) Union MoS Shri Prataprao Jadhav says India is emerging as a global source of affordable healthcare technologies through stronger science-industry partnerships ICMR launches first-of-its-kind Innovator–Industry Platform, transfers 41 Public Health Technologies to Industry India witnesses first-ever transfer of inactivated KFD and Chandipura virus biomaterials to industry partners to strengthen biomedical research and vaccine manufacturing “India has scientific capability to emerge as global leader in health technologies”: Member, NITI Aayog Dr Gobardhan Das Secy DHR & DG, ICMR Dr. Rajiv Bahl says Medical Innovations Patent Mitra accelerates the journey of indigenous biomedical research from laboratories to people" /> The Indian Council of Medical Research (ICMR), under the Department of Health Research, Ministry of Health and Family Welfare, Government of India, successfully organized “Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect”—India’s largest biomedical and technology transfer facilitation event today, at the Manekshaw Centre, New Delhi. The event marked the establishment of one of the country’s first structured platforms dedicated to biomedical innovation showcasing and technology transfer under the ICMR Medical Innovation Patent Mitra initiative. The initiative aims to translate indigenous biomedical research into accessible, real-world healthcare solutions through strong industry partnerships. The event was inaugurated by Shri Prataprao Ganpatrao Jadhav, Union Minister of State (Independent Charge), Ministry of Ayush, and Minister of State, Ministry of Health and Family Welfare in presence of Prof. Gobardhan Das, Member NITI. Delivering the keynote address, the Minister of State Shri Jadhav said, “This initiative marks a decisive step in connecting Indian science with industry, ensuring that innovations developed in our laboratories translate into technologies that strengthen public health and advance Viksit Bharat. India is moving from being a consumer of health technologies to becoming a global source of affordable and innovative healthcare solutions, powered by institutions like ICMR and strong industry partnerships.” Speaking on the occasion, Dr Gobardhan Das, Member, NITI Aayog said, “India has the scientific capability and innovation ecosystem to emerge as a global leader in health technologies. Medical Innovation Patent Mitra will play a crucial role in protecting intellectual property, enabling technology transfer and accelerating the journey of indigenous innovations from laboratories to society.” Dr. Rajiv Bahl, Director General, ICMR and Secretary, Department of Health Research, said, “Medical Innovations Patent Mitra reflects ICMR’s commitment to ensuring that cutting-edge research moves beyond laboratories to reach people through strong industry partnerships and impactful technology transfer.” During the event, the ‘Indian Biomedical Patent Landscape Report’ and the ‘Technology Compendium’ were also released, marking a significant step towards strengthening India’s biomedical innovation, intellectual property and technology transfer ecosystem. A major highlight of the event was the transfer of 41 public health technologies from ICMR institutes and innovators to industry partners for further development, manufacturing and commercialization. These technologies include advanced diagnostics, vaccines, medical devices and biomedical solutions addressing critical public health priorities. Among the technologies transferred were glycoconjugate and recombinant vaccines for Typhoid and Paratyphoid, as well as diagnostic technologies for diseases such as Japanese Encephalitis, Tuberculosis and Mpox. In another significant first, well-characterized biomaterials including inactivated KFD and Chandipura viruses were also transferred to industry partners, strengthening India’s biomedical research and manufacturing ecosystem. The event also showcased more than 100 technologies in diagnostics, therapeutics and medical devices developed by ICMR institutes, researchers and startups, while facilitating direct engagement between innovators and industry stakeholders. Innovators and Industry connect initiative is expected to play a pivotal role in strengthening India’s Biomedical sector for Viksit Bharat 2047 with stronger Public-Private partnership. <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image001OSVK.jpg" style="height:497px; width:602px" /> <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image00222QF.jpg" style="height:482px; width:602px" /> <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image003OTZ3.jpg" style="font-family:"Times New Roman",Times,serif; font-size:16px; height:361px; width:602px" /> <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image00433UY.jpg" style="font-family:"Times New Roman",Times,serif; font-size:16px; height:345px; width:602px" /> <img src="https://static.pib.gov.in/WriteReadData/userfiles/image/image005EHY3.jpg" style="height:317px; width:602px" /> *** SR/GS " /> var mPlayer = document.getElementById("background_music"); var mPlayAction = document.getElementById("playbutton"); var isPlaying = false; function playAudio() { mPlayer.play(); isPlaying = true; document.getElementById('stopA').style.display = "block"; document.getElementById('playA').style.display = "none"; } function pauseAudio() { mPlayer.pause(); isPlaying = false; document.getElementById('playA').style.display = "block"; document.getElementById('stopA').style.display = "none"; } //function HandleAudio() { // if (isPlaying == true) { // //Playing already Pause it // pauseAudio(); // } else { // //Play the music // playAudio(); // } //} var synth = window.speechSynthesis; function CleanHtml(html) { html = html.replace(/ /gi, ''); return html; } function stripHtml(html) { let tmp = document.createElement("DIV"); tmp.innerHTML = CleanHtml(html); return tmp.textContent || tmp.innerText || ""; } $(document).ready(function () { //for responsive tables $("table").each(function () { if (!$(this).closest(".table-responsive").length) { $(this).wrap(" "); } }); var width = $(window).width(); if (width $(document).ready(function () { var width = $(window).width(); if (width @media print { .sticky-social, .sticky-social_mb, .pull-right, #printPDF { display: none !important; } } .f_vl { padding-right: 30px; font-size: 17px; cursor: pointer; } .log_oo { // width: 20%; display: flex; justify-content: space-between; } .log_oo img { width: 150px; /*width: 100%; height: auto;*/ } .sticky-social_mb { position: fixed; bottom: 0px; padding: 0px; margin: 0px; width: 100%; } .social_mb { list-style: none; display: flex; width: 100%; margin-bottom: -8px; } .social_mb a { padding: 8px 0px; font-size: 30px; transition: all 0.8s ease-in-out; width: 20% !important; text-align: center; } .section1 { position: relative; padding: 10px 0px; width: 100%; } .sticky-social { position: fixed; top: 20px; left: 0px; padding: 0px; margin: 0px; } .social { list-style: none; } .social a li { padding: 8px 12px; font-size: 25px; transition: all 0.8s ease-in-out; } .social a li:hover { margin-right: -30px; box-shadow: 2px 5px 10px grey; } .social a li:hover .fa { margin-left: 20px; } .fb_b { /* background-color: rgb(59, 89, 152);*/ background-color: rgba(65,103,178,255); } .twitter_r { /* background-color: rgb(29, 161, 242);*/ background-color: #000000; } .whatsapp_r { /* background-color: rgb(77, 194, 71);*/ background-color: rgba(13,191,67,255); } .fa-envelope_r { /* background-color: rgb(219, 68, 55);*/ background-color: #e2123d; } .fa-linkedin_r { background-color: rgb(0, 119, 181); } @media only screen and (max-device-width: 767px) { p span img { max-width: 90% !important; height: auto !important; } p img { max-width: 90% !important; height: auto !important; } h2 { font-size: 20px !important; font-weight: 600 !important; } h3 { font-size: 18px !important; font-weight: 600 !important; } } /* === Film Roll Badge Styling(IFFI2025 countdown) === */ .film-roll-badge { position: absolute; top:82%; right: 20px; width: 230px; height: 70px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 18px, #6e2b8b 18px, #6e2b8b 36px ); border-top: 8px solid #9a2375; border-bottom: 8px solid #9a2375; border-radius: 8px; overflow: hidden; box-shadow: 0 4px 12px rgba(0, 0, 0, 0.4); animation: moveFilm 8s linear infinite; z-index: 10; } /* film sprocket holes */ .film-roll-badge::before, .film-roll-badge::after { content: ""; position: absolute; width: 100%; height: 10px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 10px, #fff 10px, #fff 20px ); left: 0; z-index: 2; } .film-roll-badge::before { top: -4px; } .film-roll-badge::after { bottom: -4px; } .film-roll-inner { position: relative; height: 100%; display: flex; align-items: center; justify-content: center; animation: flicker 2s infinite ease-in-out; } .countdown-text { font-size: 1.3rem; font-weight: 700; color: #fff; text-shadow: 0 0 6px rgba(255, 255, 255, 0.4), 0 0 10px #000; white-space: nowrap; } /* === Animations === */ @keyframes moveFilm { 0% { background-position: 0 0; } 100% { background-position: 120px 0; } } @keyframes flicker { 0%, 100% { opacity: 1; } 50% { opacity: 0.9; } 25% { opacity: 0.95; } 75% { opacity: 0.85; } } /* === Responsive Adjustments === */ @media (max-width: 1500px) { .film-roll-badge { top: 68%; right: 18px; /* width: 220px; */ height: 65px; font-size: 0.85rem; } .press-section { margin-top: 35px; } } @media (max-width: 992px) { .film-roll-badge { top: 52%; right: 10px; width: 200px; height: 60px; } } @media (max-width: 768px) { .film-roll-badge { top: 56%; right: 10px; width: 124px; height: 55px; } .countdown-text { font-size: 0.9rem; } } @media (max-width: 576px) { .film-roll-badge { top: 59%; right: 5px; /* width: 160px; */ height: 50px; } .countdown-text { font-size: 0.85rem; } } const festivalStart = new Date("2025-11-20T00:00:00").getTime(); const festivalEnd = new Date("2025-11-28T23:59:59").getTime(); const countdownElement = document.getElementById("countdown"); const interval = setInterval(() => { const now = new Date().getTime(); // BEFORE FESTIVAL — show days + hours left if (now = festivalStart && now el.style.width = "350px"); clearInterval(interval); } }, 1000); //

Original PIB release
pib.gov.in · PRID 2264989

Open on PIB ↗

Indian Council of Medical Research organizes India’s largest biomedical innovation and technology transfer event “Medical Innovations Patent Mitra: Innovators-to-Industry (I2I) Connect” in New Delhi

More from this day